Multi-drug resistant infections medicine 'Zaynich' to get USFDA approval next year: Wockhardt Chairman Ruchika Sharma14 April 2025 3:49 PM ISTDubai: Zaynich, a multi-drug resistant infections medicine, is set to receive the US Food and Drug Administration (USFDA) approval in 2026,...
US tariffs on pharma sector would be counterproductive for Americans, says Wockhardt Chairman Ruchika Sharma13 April 2025 3:15 PM ISTWockhardt Chairman Habib Khorakiwala said that U.S. tariffs on pharmaceutical products would ultimately be counterproductive for Americans.The U.S....
Wockhardt Zaynich successfully treats paediatric cancer patient with recalcitrant blood, liver infection Ruchika Sharma1 April 2025 12:15 PM ISTThe patient was treated with Zaynich for 41 days, resulting in the successful resolution of the infection.
Zaynich shows over 97 percent efficacy for drug-resistant bacteria: Wockhardt Ruchika Sharma13 Jan 2025 1:06 PM ISTMumbai: Wockhardt has announced that Zaynich (Zidebactam/Cefepime, WCK 5222) demonstrated over 97 percent clinical efficacy in treating...
USFDA grants fast track designation to Wockhardt novel antibiotic WCK 6777 Ruchika Sharma8 Oct 2024 10:30 AM ISTMumbai: Wockhardt has announced that its unique once-a-day, β-lactam enhancer based MDR-active antibiotic, WCK 6777 (Ertapenem/Zidebactam) has...
Wockhardt group Founder Chairman Dr Habil Khorakiwala bags Lifetime Achievement Award at 10th IHW summit in Dubai Ruchika Sharma27 Sept 2024 1:04 PM ISTMumbai: Founder Chairman of Wockhardt group, Dr Habil Khorakiwala was presented the Lifetime Achievement Award at the 10th Integrated Health...
Wockhardt plans to launch antibiotic Zaynich in early FY26 Ruchika Sharma30 Jun 2024 2:00 PM ISTMumbai: Wockhardt said that research and trials for the antibiotic Zaynich are advancing well, with plans for an early launch in FY26. Habil...
Wockhardt raises Rs 480 crores via QIP Ruchika Sharma30 March 2024 1:15 PM ISTWith the closure of its recent Qualified Institutional Placement (QIP), Wockhardt has now raised Rs 480 crores. The share allotment committee allotted...
Wockhardt loss narrows to Rs 86 crore in Q3 Ruchika Sharma17 Feb 2024 10:00 AM ISTNew Delhi: Pharmaceuticals firm Wockhardt Ltd has reported narrowing of consolidated net loss to Rs 86 crore for the third quarter ended December...
Wockhardt shareholders reject resolution on related party transaction Ruchika Sharma18 Aug 2023 1:30 PM ISTNew Delhi: Shareholders of pharma firm Wockhardt Ltd have rejected a resolution on a related party transaction that seeks to allow the company to...
Wockhardt Former executive banned from securities market for six months for insider trading Ruchika Sharma21 Jun 2023 3:30 PM ISTNew Delhi: Sebi has barred Yatendra Kumar, a former executive of Wockhardt Ltd, from the securities market for six months and directed him to disgorge...
Wockhardt, its directors settle insider trading case with Sebi in Rs 76.68 lakh Ruchika Sharma23 May 2023 11:40 AM ISTIt was alleged that they had violated the Securities Contracts (Regulation) Act (SCRA) and insider trading rules.
